See every side of every news story
Published loading...Updated

Drug-Coated Balloon-Only Percutaneous Coronary Intervention in Acute Coronary Syndrome: Are We Sacrificing Individualized Pharmacotherapy for Simplicity?

Summary by The BMJ
Agreement: I AgreeBody: Dear Editor We read with interest the REC-CAGEFREE II trial evaluating stepwise DAPT de-escalation following DCB-only PCI in ACS patients [1]. Despite its clinical relevance, we believe several methodological and ethical concerns undermine the generalizability of its conclusions. Pharmacologically, the trial used various paclitaxel-coated balloons without subgroup stratification, introducing heterogeneity in drug delivery…

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

The BMJ broke the news in on Sunday, April 13, 2025.
Sources are mostly out of (0)

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.